YONSEI UNIVERSITY;INDUSTRY-ACADEMIC COOPERATION FOUNDATION
发明人:
CHANG, HANG SEOK,장항석,KIM, SEOK MO,김석모,PARK, KI CHEONG,박기청,CHANG, HANG SEOKKR,KIM, SEOK MOKR,PARK, KI CHEONGKR
申请号：
KR1020160087562
公开号：
KR1018001290000B1
申请日:
2016.07.11
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating cancer and, more specifically, to a pharmaceutical composition capable of effectively preventing or treating thyroid cancer by effectively inhibiting growth of cancer cells or cancer stem cells. The pharmaceutical composition includes a histone deacetylation inhibitor (HDAC inhibitor) and a kinase inhibitor as active ingredients, wherein the histone deacetylation inhibitor is a compound represented by chemical formula 1, and the kinase inhibitor is a compound represented by chemical formula 2.본 발명은 암의 예방 또는 치료용 약학적 조성물에 관한 것으로, 보다 상세하게는 암 세포 또는 암 줄기세포의 성장을 효과적으로 억제하여 암을 효과적으로 예방 또는 치료할 수 있는 약학적 조성물에 관한 것이다.
